Skip to content
Review Open access

Benchmarking Open-Source Pathology Foundation Models for Breast Cancer Biomarker Prediction from H&E Whole-Slide Images

Aug 2026 · Cancers · Vol 18, pp. 2475 · 0 citations · 37 references
Medicine

TL;DR

This study compares two open-source pathology foundation models—TITAN and CHIEF—for ER, PR, and HER2 prediction on the publicly available TCGA-BRCA cohort, under a strict patient-level evaluation protocol with 10 random partitions and 95% confidence intervals.

Abstract

Simple Summary Breast cancer treatment is guided by three molecular biomarkers—estrogen receptor (ER), progesterone receptor (PR), and HER2—typically measured by immunohistochemistry (IHC), a process that requires additional staining, time, and specialist review. Whole-slide image (WSI) foundation models are large pre-trained neural networks that summarize a digital biopsy into a compact representation, raising the possibility of inferring biomarker status directly from routinely stained H&E images. In this study, we compare two open-source pathology foundation models—TITAN and CHIEF—for ER, PR, and HER2 prediction on the publicly available TCGA-BRCA cohort, under a strict patient-level evaluation protocol with 10 random partitions and 95% confidence intervals. ER and PR predictions show robust discriminative performance under retrospective evaluation; HER2 prediction at the default decision threshold remains limited and motivates threshold-calibration and multimodal extensions. The findings are hypothesis-generating and motivate prospective external validation before any clinical use.

Read PDF

Similar papers

Oct 2026

Foundation Model-Based Computational Pathology Predicts Breast Cancer Biomarker Status from Intraoperative Frozen Sections.

Prediction of breast cancer biomarkers from routine formalin-fixed, paraffin-embedded (FFPE) hematoxylin and eosin (H&E) images has been explored previously, but whether biomarker-associated morphologic signals can be reliably captured from artifact-prone intraoperative frozen-section (FS) specimens remains insufficien...

Shun Liu, Jun Li, Yi-Xiang Lian et al. · 0 citations
Open access Sep 2026

Virtual immunohistochemistry for ER and PR prediction in breast cancer histopathology: a two-stage conditional generative framework

Background Immunohistochemistry (IHC) remains the gold standard for assessing key breast cancer biomarkers such as estrogen receptor (ER) and progesterone receptor (PR). However, the staining process is resource-intensive, time-consuming, and dependent on specialized laboratory infrastructure. While recent advances in...

Hiba Alzoubi, Abdulla Shatarah, Abdulrhman Sanajleh et al. · 0 citations
Open access Aug 2026

Benchmarking of pathology foundation models for assessing HER2 amplification and CEP17 polysomy in breast cancer

Accurate assessment of Human Epidermal Growth Factor Receptor 2 (HER2) amplification and Chromosome 17 (CEP17) copy number is critical for breast cancer treatment, yet diagnostically equivocal (IHC 2+) cases remain a clinical bottleneck. This study systematically benchmarks 14 feature encoders, including 12 Pathology...

Qing-Jie Lv, Xin Yu, Tao Wang et al. · 0 citations
Open access Sep 2026

Deep learning-based large-scale pan-cancer multiple biomarkers prediction using RIDGE with pathological images

Molecular profiling tests currently relies significantly on genomics or transcriptomics analysis, leading a prolonged turnaround time and higher costs procedure. This comprehensive pan-cancer study aims to develop a general, weakly supervised, and clinically interpretable deep learning (DL) approach for predictin...

Hao-Ran Xi, Xiao-Bing Feng, Ye Lu et al. · 0 citations
Open access Oct 2026

Dual-Foundation-Model Ensemble Predicts Gene Expression in Muscle-Invasive Bladder Cancer for Patient Outcome Stratification.

Muscle-invasive bladder cancer (MIBC) exhibits significant heterogeneity in clinical outcomes and treatment responses. While gene expression profiling has provided important biological and prognostic insight, transcriptomic assays are not routinely incorporated into standard clinical practice, in part due to cost. AI m...

I. F. Mathisen, F. Koll, R. Mayer et al. · 0 citations
Open access Sep 2026

An evaluation of pathology foundation models with weakly supervised learning for BRAF mutation prediction in melanoma whole slide images

Overall, foundation models combined with weakly supervised learning provide competitive performance for BRAF status prediction in melanoma WSIs, but the findings highlight the need for diverse melanoma datasets and the importance of evaluating model performance beyond a single metric when developing H&E-based computati...

Lucy Godson, Jack Breen, Alexander I. Wright et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.